JAVELIN Bladder Medley trial: avelumab-based combinations as first-line maintenance in advanced urothelial carcinoma
Summary
Our partner journal Future Oncology has recently published a Clinical Trial Protocol manuscript, which details the Phase II JAVELIN Bladder Medley umbrella trial. The trial is exploring novel combinations with avelumab as first-line maintenance therapy for advanced urothelial carcinoma after first-line chemotherapy (NCT05327530).
View the full article